COMBINATION DRUG THERAPIES

Combination drag therapies comprising a 5-HTZA receptor agonist and an N-methyl-D-aspartate (NMDA) receptor antagonist (e.g., nitrous oxide, ketamine, etc.) are provided. Also described are pharmaceutical compositions and methods of treating a central nervous system (CNS) disorder or a psychiatric d...

Full description

Saved in:
Bibliographic Details
Main Authors MINO, Robert, PALFREYMAN, Michael, NIVOROZHKIN, Alex, GREENE, Brett J
Format Patent
LanguageEnglish
French
German
Published 17.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Combination drag therapies comprising a 5-HTZA receptor agonist and an N-methyl-D-aspartate (NMDA) receptor antagonist (e.g., nitrous oxide, ketamine, etc.) are provided. Also described are pharmaceutical compositions and methods of treating a central nervous system (CNS) disorder or a psychiatric disease using the combination drug therapy, for example, via aerosol inhalation.
AbstractList Combination drag therapies comprising a 5-HTZA receptor agonist and an N-methyl-D-aspartate (NMDA) receptor antagonist (e.g., nitrous oxide, ketamine, etc.) are provided. Also described are pharmaceutical compositions and methods of treating a central nervous system (CNS) disorder or a psychiatric disease using the combination drug therapy, for example, via aerosol inhalation.
Author MINO, Robert
NIVOROZHKIN, Alex
GREENE, Brett J
PALFREYMAN, Michael
Author_xml – fullname: MINO, Robert
– fullname: PALFREYMAN, Michael
– fullname: NIVOROZHKIN, Alex
– fullname: GREENE, Brett J
BookMark eNrjYmDJy89L5WSQcvb3dfL0cwzx9PdTcAkKdVcI8XANcgzwdA3mYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgEmxpYWFuaGjobGRCgBAMovIcE
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate ASSOCIATIONS MÉDICAMENTEUSES
KOMBINATIONSTHERAPIEN MIT ARZNEIMITTELN
ExternalDocumentID EP4398871A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP4398871A13
IEDL.DBID EVB
IngestDate Fri Sep 27 05:31:19 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP4398871A13
Notes Application Number: EP20220716971
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240717&DB=EPODOC&CC=EP&NR=4398871A1
ParticipantIDs epo_espacenet_EP4398871A1
PublicationCentury 2000
PublicationDate 20240717
PublicationDateYYYYMMDD 2024-07-17
PublicationDate_xml – month: 07
  year: 2024
  text: 20240717
  day: 17
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies Cybin IRL Limited
RelatedCompanies_xml – name: Cybin IRL Limited
Score 3.5600283
Snippet Combination drag therapies comprising a 5-HTZA receptor agonist and an N-methyl-D-aspartate (NMDA) receptor antagonist (e.g., nitrous oxide, ketamine, etc.)...
SourceID epo
SourceType Open Access Repository
SubjectTerms DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title COMBINATION DRUG THERAPIES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240717&DB=EPODOC&locale=&CC=EP&NR=4398871A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsUgyNAedY66baGiSrGuSlpiim5SakqJrkmJsmGaZaG6Ylgg-7dPPzCPUxCvCNIKJIRO2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHkO6JmouTrWuAv4u_s5qzM5Cl5hdkC6x3gdnJ0BHYUWIFtaJBx-y7hjmBNqUUINcoboIMbAFAw_JKhBiYUvOEGTidYRevCTNw-ELnu4FMaNYrFmGQcvb3dfKEHF6r4BIU6q4Q4uEa5BgAbM6JMii4uYY4e-gCLYmHeyjeNQDuHGMxBhZgPz9VgkHB2BQYcIkGSQYWSSkmxsB6H9hUSUxJskxONU0CtiOSJBkkcRojhUdOmoELFDK64NMgZRhYSopKU2WBNWlJkhw4DAB7vXUB
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsUgyNAedY66baGiSrGuSlpiim5SakqJrkmJsmGaZaG6Ylgg-7dPPzCPUxCvCNIKJIRO2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHkO6JmouTrWuAv4u_s5qzM5Cl5hdkC6x3gdnJ0BHYUWI1B_YIQcfsu4Y5gTalFCDXKG6CDGwBQMPySoQYmFLzhBk4nWEXrwkzcPhC57uBTGjWKxZhkHL293XyhBxeq-ASFOquEOLhGuQYAGzOiTIouLmGOHvoAi2Jh3so3jUA7hxjMQYWYD8_VYJBwdgUGHCJBkkGFkkpJsbAeh_YVElMSbJMTjVNArYjkiQZJHEaI4VHTp6B0yPE1yfex9PPW5qBCxRKuuCTIWUYWEqKSlNlgbVqSZIcODwAGcJ37A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMBINATION+DRUG+THERAPIES&rft.inventor=MINO%2C+Robert&rft.inventor=PALFREYMAN%2C+Michael&rft.inventor=NIVOROZHKIN%2C+Alex&rft.inventor=GREENE%2C+Brett+J&rft.date=2024-07-17&rft.externalDBID=A1&rft.externalDocID=EP4398871A1